by TGAR Foundation | May 20, 2026 | General
Antimicrobial resistance (AMR) is a challenge for modern medicine. The risks of AMR extend beyond antibiotics, affecting cancer treatment, R&D in life sciences and more. Recognizing AMR as a foundational threat to clinical innovation is a necessary first step, but...
by TGAR Foundation | Apr 30, 2026 | General
Paolo fell ill with a serious urinary infection with an E.coli resistant to many antibiotics. It took two months and three courses of different antibiotics before Paolo’s infection was successfully treated. Nobody knows where he picked up the infection. Paolo is...
by TGAR Foundation | Apr 16, 2026 | General
Culture-independent antibiotic resistance gene analyses enable broad explorations of microbial communities but often fail to link such genes to bacterial hosts and genetic contexts. This makes assessing prevalence of resistant pathogens and likelihood of further...
by TGAR Foundation | Mar 24, 2026 | General
Advancing Awareness, Research, and Collaboration Against AMR The Global Antibiotic Resistance Foundation continues to strengthen its internationalcollaborations and outreach efforts to combat antimicrobial resistance (AMR). Over the pastmonths, several important...
by TGAR Foundation | Feb 25, 2026 | General
In the modern world, capitalism drives innovation, economic growth, and consumerism.However, like any powerful system, it also has unintended consequences. One suchconsequence is the growing threat of antibiotic resistance. The intersection of capitalistforces and the...
